The role of macrophages in immune-mediated damage to the peripheral nervous system

Progress in Neurobiology

Volumn 64, Issue 2, 2001, Pages 109-127

  Kiefer, Reinhard ^a   Kieseier, Bernd C ^b   Stoll, Guido ^c   Hartung, Hans Peter ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Demyelination; Inflammatory; T cell

Indexed keywords

AUTOANTIBODY; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; FREE RADICAL; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; METALLOPROTEINASE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNITY; CELL INFILTRATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COMPLEMENT DEPENDENT CYTOTOXICITY; DISEASE COURSE; GUILLAIN BARRE SYNDROME; HISTOCOMPATIBILITY; HUMAN; IMMUNE MEDIATED INJURY; INFLAMMATION; MACROPHAGE; MACROPHAGE MIGRATION; MYELIN SHEATH; NERVE CELL GROWTH; NERVE FIBER; NEUROPATHOLOGY; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; SCHWANN CELL; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; ANTIGEN PRESENTATION; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGES; PERIPHERAL NERVOUS SYSTEM; POLYRADICULONEUROPATHY;

EID: 0035123658     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00060-5     Document Type: Review

References (214)

1. Do macrophages kill through apoptosis?
2. Association between Campylobacter infection and Guillain-Barré syndrome
3. Neurotrophic factors in peripheral neuropathies: Therapeutic implications
4. Suppression of experimental allergic neuritis by an antibody to the intercellular adhesion molecule ICAM-1
5. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis
6. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1
7. Attenuation of experimental autoimmune neuritis in the Lewis rat by treatment with an antibody to L-selectin
8. The role of integrins in immune-mediated diseases of the nervous system
9. Rat and human Schwann cells in vitro can synthesize and express MHC molecules
10. Acute inflammatory demyelinating polyradiculoneuropathy
11. Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve
12. Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons
13. IL-10 suppresses experimental autoimmune neuritis and down-regulates cytokine mRNA expression of Th1 and macrophage source
14. Molecular mimicry: A mechanism for autoimmune injury
15. Fulminant Guillain-Barre syndrome with universal inexcitability of peripheral nerves: A clinicopathological study
16. The role of non-resident cells in wallerian degeneration
17. Myelin phagocytosis in wallerian degeneration of peripheral nerves depends on silica-sensitive Bg/Bg-negative and Fc-positive monocytes
18. Multifocal motor neuropathy
19. Proteolytic remodeling of extracellular matrix
20. Interleukin 6 production by Schwann cells and induction in sciatic nerve injury
21. Human peripheral nerve macrophages in normal and pathological conditions
22. Quantification of interleukin 6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction
23. Adhesion molecules involved in macrophage responses to wallerian degeneration in the murine peripheral nervous system
24. The role of macrophages in wallerian degeneration
25. L-fucosidase treatment blocks myelin phagocytosis by macrophages in vitro
26. Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro
27. TNF-alpha suppresses CR3-mediated myelin removal by macrophages
28. Dorsal root ganglia co-cultured with macrophages: An in vitro model to study experimental demyelination
29. Expression of JE (monocyte chemoattractant protein-1) is induced by sciatic axotomy in wild type rodents but not C57BL/Wld mice
30. Disorder in human myelin induced by superoxide radical: An in vitro investigation
31. Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain Barré syndrome
32. Circulating transforming growth factor beta 1 (TGF-(1) in Guillain-Barré syndrome: Decreased concentrations in the early course and increase with motor function
33. Complement depletion reduces macrophage infiltration and activation during wallerian degeneration and axonal regeneration
34. Advances in chronic inflammatory demyelinating polyneuropathy: Disease variants and inflammatory response mediators and modifiers
35. Vasculitis confined to peripheral nerves
36. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
37. Local effects of recombinant rat interleukin-6 on the peripheral nervous system
38. Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6
39. Macrophage heterogeneity established by immunocytochemistry
40. The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat
41. Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis
42. Tumour necrosis factor-α and other cytokines in Guillain-Barré syndrome
43. An acute axonal form of Guillain-Barre polyneuropathy
44. Antisulfatide polyneuropathy: Antibody-mediated complement attack on peripheral myelin
45. Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials
46. Spinal cord microglia in experimental allergic neuritis: Evidence for fast and remote activation
47. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: Comparison between immune-mediated demyelination and Wallerian degeneration
48. Synergistic effect of IFN-γ and TNF-α on expression of immune molecules and antigen presentation by Schwann cells
49. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms
50. Mechanisms of immune regulation in the peripheral nervous system
51. Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis
52. Animal models for autoimmune demyelinating disorders of the nervous system
53. Opsonization of normal myelin by anti-myelin antibodies and normal serum
54. Identity of ED2-positiperivascular cells in rat brain
55. CD28/B7 costimulation: A review
56. Regulation of experimental autoimmune neuritis by transforming growth factor-β l
57. Macrophage responses and myelin clearance during Wallerian degeneration: Relevance to immune-mediated demyelination
58. Macrophage systems in peripheral nerves. A review
59. Guillain-Barre syndrome in Northern China: The spectrum of neuropathological changes in clinically defined cases
60. Pathology of the motor sensory axonal Guillain-Barre syndrome
61. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barre syndrome
62. Electrophysiological classification of Guillain-Barré syndrome: Clinical associations and outcome
63. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy
64. Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
65. Induction of myelin gene expression in Schwann cell cultures by an interleukin-6 receptor-interleukin-6 chimera
66. Guillain-Barre syndrome
67. Myelin phagocytosis by peritoneal macrophages in organ cultures of mouse peripheral nerve. A new model for studying myelin phagocytosis in vitro
68. Guillain-Barre syndrome: Activated complement components C3a and C5a in CSF
69. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis: Serial electrophysiological, biochemical and morphological observations
70. The role of interferon-γ in the pathogenesis of experimental autoimmune disease of the peripheral nervous system
71. Serum levels of soluble E-selectin (ELAM-1) in immune mediated neuropathies
72. Immunopathogenesis and treatment of the Guillain-Barré syndrome, parts I and II
73. Circulating adhesion molecules and inflammatory mediators in demyelination: A review
74. Autoimmunity in the peripheral nervous system
75. Guillain-Barre syndrome, CIDP and other chronic immune-mediated neuropathies
76. Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy
77. Immune reactive C3d on the surface of myelin sheaths in neuropathy
78. Bone marrow-derived elements in the central nervous system: An immunohistochemical and ultrastructural survey of rat chimeras
79. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma
80. Guillain-Barre syndrome
81. Human autoimmune neuropathies
82. Anti GDla antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome
83. Matrix metalloprotease expression during experimental autoimmune neuritis
84. Sural nerve biopsies in Guillain-Barré syndrome: Axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome
85. Pathogenesis of Guillain-Barré syndrome
86. Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system
87. Selective elimination of macrophages by dichlormethylene diphosphonate containing liposomes suppresses experimental autoimmune neuritis
88. Therapeutic effect of transforming growth factor-β2 on actively induced EAN but not adoptive transfer EAN
89. Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats
90. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies
91. Characterization of a novel tumor-derived cytokine: Endothelial-monocyte activating polypeptide II
92. Transforming growth factor-β expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis
93. Transforming growth factor-βl: A lesion-associated cytokine of the nervous system
94. Transfom-ting growth factor-β1 in experimental autoimmune neuritis: Cellular localization and time course
95. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies
96. Enhanced 137 costimulatory molecule expression in inflammatory human sural nerve biopsies
97. Matrix metalloproteases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome
98. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon 50 gamma pretreatment: Synergistic effects of interferon-γ and tumor necrosis factor on MHC class II induction
99. The antibody repertoire in experimental allergic neuritis: Evidence for PMP-22 as a novel neuritogen
100. Effect of reactive oxygen species on myelin membrane proteins
101. Mechanisms of Schwann cell damage in inflammatory neuropathy
102. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: Quantitative and kinetic determination of serum antibody by complement component 1 fixation
103. Activation of terminal components of complement in patients with Guillain-Barre syndrome and other demyelinating neuropathies
104. Microglia: A sensor for pathological events in the CNS
105. Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia
106. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
107. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy
108. Concentration-dependent effects of pentoxifylline on migration and myelin phagocytosis by macrophages
109. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve
110. The role of cytokines in Schwann cell damage, protection, and repair
111. TNF is a potent anti-inflammatory cytokine in autoimmune mediated demyelination
112. The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain Barre syndrome: Preliminary communication
113. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-α activated vascular endothelium under flow in vitro
114. Chemokines-chemotactic cytokines that mediate inflammation
115. Central nervous system pathology in patients with the Guillain-Barré syndrome
116. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
117. Nerve biopsy in children with severe Guillain Barre syndrome and inexcitable motor nerves
118. TNF-α, IFN-γ and IL-2 mRNA expression in CIDP sural nerve biopsies
119. The neurobiology of Schwann cells
120. Mediation of inflammation by encephalitogenic cells: Interferon gamma induction of nitric oxide synthase and cyclooxygenase 2
121. Apoptosis induction by macrophage-derived reactive oxygen species in myelin-specific T cells requires cell-cell contact
122. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy
123. MHC-positive, ramified macrophages in the normal and injured rat peripheral nervous system
124. The vasculitides
125. Receptor-mediated phagocytosis of myelin by macrophages and microglia: Effect of opsonization and receptor blocking agents
126. Receptor-mediated phagocytosis of myelin by macrophages and microglia: Effect of opsonization and receptor blocking agents
127. Identification of resident macrophages in the normal and injured rat peripheral nervous system
128. Induction of interleukin-6 in axotomized sensory neurons
129. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons
130. Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy
131. Cytokines in context
132. Immunological characterization of sural nerve biopsies from patients with Guillain-Barré syndrome
133. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
134. Tumor necrosis factor-α in peripheral nerve lesions
135. Inflammation and severe demyelination in the peripheral nervous system induced by the intraneural injection of recombinant mouse interleukin-12
136. The macrophage response to central and peripheral nerve injury: A possible role for macrophages in regeneration
137. Radiation-induced reductions in macrophage recruitment have only slight effects on myelin degeneration in sectioned peripheral nerves of mice
138. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy
139. Class 11 antigen expression and inflammatory cells in the Guillain-Barré syndrome
140. Response of the axon and barrier endothelium to experimental allergic neuritis induced by autoreactive T cell lines
141. Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome
142. Acute idiopathic polyneuritis
143. Pathology of the Guillain-Barré syndrome
144. Chronic relapsing polyneuritis
145. Autoantibodies associated with peripheral neuropathy
146. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function
147. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor
148. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-α processing attenuates experimental autoimmune neuritis
149. Interleukin 6 in intact and injured mouse peripheral nerves
150. Focal lesions are a feature of chronic inflammatory demyelinating polyneuropathy (CIDP)
151. Neuropathies associated with paraproteinemia
152. Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein
153. Presence and regulation of transforming growth factor-β mRNA and protein in the normal and lesioned rat sciatic nerve
154. Necrotizing peripheral nerve vasculitis
155. Nerve lesions induced by macrophage activation
156. Quantitative assessment of class II molecules in normal and pathological nerves. Immunocytochemical studies in vivo and in tissue culture
157. Axons modulate the expression of transforming growth factor-β in Schwann cells
158. Localization of endothelial monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: Expression by monocytes and activated microglial cells
159. Macrophages but not Schwann cells express 1a antigen in experimental autoimmune neuritis
160. Transient cellular expression of interferon-γ in experimental autoimmune neuritis
161. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy
162. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
163. Elevated serum levels of tumor necrosis factor-α in Guillain-Barré syndrome
164. Circulating tumor necrosis factor-α correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome
165. Paraproteinemia and neuropathy
166. Potential role of transforming growth factor-β1 in terminating the immune response in patients with Guillain-Barré syndrome
167. Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP
168. Axonal pathology in Japanese Guillain-Barre syndrome: A study of 15 autopsied cases
169. Intraneural activated T cells cause focal breakdown of the blood-nerve barrier
170. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
171. Paraproteinaemic neuropathies
172. Role of endoneural cells in experimental allergic neuritis and characterisation of a resident phagocytic cell
173. Nerve injury, axonal degeneration and neural regeneration: Basic insights
174. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation
175. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system
176. Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system
177. Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system
178. Tumor necrosis factor-α in immune mediated demyelination and Wallerian degeneration of the rat peripheral nervous system
179. Major histocompatibility complex class II expression and macrophage responses in genetically proven Charcot-Marie-Tooth type I and hereditary neuropathy with liability to pressure palsies
180. Unraveling immune privilege
181. The dynamics of macrophage recruitment after nerve transection
182. The selectins: Vascular adhesion molecules
183. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve
184. Chronic inflammatory polyneuritis and related polyneuropathies
185. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
186. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system
187. Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages
188. Effect of rhTNF-α injection into rat sciatic nerve
189. Reactive oxygen species are required for the phagocytosis of myelin by macrophages
190. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide
191. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids
192. Intrathecal application of interferon-g: Progressive appearance of MHC antigens within the nervous system
193. Bone marrow-derived elements in the peripheral nervous system
194. The expression of CD59 in experimental allergic neuritis
195. Wallerian degeneration in ICAM-1-deficient mice
196. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis
197. Complement depletion affects demyelination and inflammation in experimental allergic neuritis
198. Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis
199. Role of TNF-α in high-dose antigen therapy in experimental autoimmune neuritis: Inhibition of TNF-α by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis
200. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes
201. Cellular immune reactivity within the CNS
202. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
203. The family of matrix metalloproteinases
204. Monocytes are required to prime peripheral blood T cells to undergo apoptosis
205. Astroglial overproduction of TGF-β 1 enhances inflammatory central nervous system disease in transgenic mice
206. Local expression of immunoregulatory IL-l2p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice
207. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome
208. Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat
209. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro
210. Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice
211. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1
212. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and cytolysin
213. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis
214. Dynamics of production of MIP-1α, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats